— Know what they know.
Not Investment Advice
Also trades as: CSLLY (OTC) · $vol 11M · CMXHF (OTC) · $vol 0M

CSL.AX ASX

CSL Limited
1W: -0.9% 1M: +1.2% 3M: +41.5% YTD: +2.3% 1Y: -14.9% 3Y: -32.6% 5Y: -39.2%
A$175.35 ($121.95)
-2.89 (-1.62%)
 
Weekly Expected Move ±3.5%
A$163 A$169 A$175 A$182 A$188
ASX · Healthcare · Biotechnology · Tech Score Buy · Power 59 · A$84.0B mcap · 482M float · 0.330% daily turnover

Cash Flow Trends

Operating Cash Flow
$3.6B +0.8% ▲
5Y CAGR: -0.3%
Capital Expenditures
$660M +35.1% ▲
5Y CAGR: -17.0%
Free Cash Flow
$2.9B +15.1% ▲
5Y CAGR: +8.3%
Dividends Paid
$1.4B -0.6% ▼
Buybacks
$740M +0.0% ▲
Net Change in Cash
-$767M -249.2% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
— Operating Activities —
Net Income$3.1B$3.3B$0$0-$2.6B
Depreciation & Amort.$748M$1.2B$0$0$1.1B
Stock-Based Comp.$169M$209M$0$0$0
Change in Working Capital-$1.2B-$938M-$1.2B$0-$627M
Other Non-Cash Items$922M$233M$4.0B$3.6B$5.8B
Operating Cash Flow$3.6B$3.9B$2.8B$3.6B$3.6B
— Investing Activities —
Capital Expenditures-$1.7B-$2.5B-$566M-$636M-$1.3B
Acquisitions (Net)-$562M-$15.5B-$3M$167M$5M
Investment Purchases-$535M$0$0$0-$5M
Investment Sales$0$404M$0$0$9M
Other Investing-$965K-$122M-$690M-$381M-$3M
Investing Cash Flow-$2.3B-$17.6B-$1.3B-$850M-$1.3B
— Financing Activities —
Net Debt Issuance$3.8B$1.7B$41M-$735M-$480M
Stock Repurchased$0$0$0$0-$740M
Dividends Paid-$1.4B-$1.6B-$1.3B-$1.4B-$1.4B
Other Financing$3.3B$516M-$99M-$89M-$258M
Financing Cash Flow$10.6B$678M-$1.3B-$2.2B-$2.9B
Net Change in Cash$12.8B-$12.9B$134M$514M-$767M
Cash End of Period$15.2B$2.3B$1.6B$2.2B$1.5B
Free Cash Flow$1.9B$1.4B$1.5B$2.5B$2.9B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms